|
Corning Life Sciences
cell culture hei-oc1 Cell Culture Hei Oc1, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hei+oc1+cells/cell+culture+hei+oc1/pmc06903403-220-0-31 Average 90 stars, based on 1 article reviews
cell culture hei-oc1 - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
KEYENCE
hei-oc1 cells ![]() Hei Oc1 Cells, supplied by KEYENCE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hei+oc1+cells/hei+oc1+cells/pmc10124869-60-34-36 Average 90 stars, based on 1 article reviews
hei-oc1 cells - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Novogene
hei oc1 cells ![]() Hei Oc1 Cells, supplied by Novogene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hei+oc1+cells/cells+hei+oc1/pmc13194610-116-0-18 Average 86 stars, based on 1 article reviews
hei oc1 cells - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
|
BioVector NTCC
hei-oc1 cells ![]() Hei Oc1 Cells, supplied by BioVector NTCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hei+oc1+cells/hei+oc1+cells/pm36639590-30-11-18 Average 90 stars, based on 1 article reviews
hei-oc1 cells - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Charles River Laboratories
corti1 hei oc1 cells ![]() Corti1 Hei Oc1 Cells, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hei+oc1+cells/cells+corti1+hei+oc1/pmc12467209-71-4-16 Average 86 stars, based on 1 article reviews
corti1 hei oc1 cells - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
|
Servicebio Inc
hei oc1 cells ![]() Hei Oc1 Cells, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/hei+oc1+cells/cells+hei+oc1/pmc12362821-252-1-13 Average 86 stars, based on 1 article reviews
hei oc1 cells - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
Image Search Results
Journal: PLOS ONE
Article Title: In vitro impact of platinum nanoparticles on inner ear related cell culture models
doi: 10.1371/journal.pone.0284794
Figure Lengend Snippet: Cell culture models of the inner ear that have been used in this study.
Article Snippet: 30 μl of the staining solution was added to 100 μl of the cell culture assays without medium exchange, followed by incubation for 30–45 minutes at room temperature and fluorescent microscopic evaluation of the
Techniques: Cell Culture
Journal: Frontiers in Molecular Neuroscience
Article Title: The H3K9me2-FOXG1-microRNA axis reduces cochlear hair cells damage by modulating autophagy in age-related hearing loss
doi: 10.3389/fnmol.2026.1834102
Figure Lengend Snippet: Construction of mimetic aging mouse and cell models with D-gal. (A) Experimental protocol for D-gal-induced mimetic aging mice. (B) Statistical analysis of the click ABR between the control group and the D-gal group ( n = 5). (C) Statistical analysis of tone burst ABR in different frequencies between the control group and the D-gal group ( n = 5). (D) Immunofluorescence staining of the cochlear from the control mice and the D-gal mice with Myosin7a (green), Phalloidin (red) and DAPI (blue). (E) Quantification of OHCs in the control group and the D-gal group ( n = 4). (F) Experimental protocol for D-gal-induced mimetic aging cells. (G) CCK-8 assay results for HEI-OC1 cells after 72-h treatment with different concentrations of D-gal ( n = 3). (H) Quantification of the mtDNA CD levels in the control group and the D-gal group ( n = 4). (I) Flow cytometric analysis of apoptosis in the control group and the D-gal group. (J) Quantification of apoptotic cells in the control group and the D-gal group ( n = 3). (K) Quantification of dead cells in the control group and the D-gal group ( n = 3). (L) Flow cytometric analysis of ROS in the control group and the D-gal group. (M) Quantification of ROS levels in the control group and the D-gal group ( n = 4). (N) TEM results of structural changes in cells from the control group and the D-gal group (Red arrows: mitochondrial pathology, Blue arrows: chromatin condensation, Yellow arrows: cytoplasmic accumulation). Control cells received an equal volume of saline. NS, not significant, * p < 0.05, ** p < 0.01, *** p < 0.001.
Article Snippet:
Techniques: Control, Immunofluorescence, Staining, CCK-8 Assay, Saline
Journal: Frontiers in Molecular Neuroscience
Article Title: The H3K9me2-FOXG1-microRNA axis reduces cochlear hair cells damage by modulating autophagy in age-related hearing loss
doi: 10.3389/fnmol.2026.1834102
Figure Lengend Snippet: Changes in FOXG1, H3K9me2, and autophagy levels following D-gal treatment. (A) Western blot of FOXG1 and LC3 expression levels in the cochlear of the control mice and the D-gal mice. D-gal (200 mg/kg/day) was administered via subcutaneous injection for 8 weeks. (B) Quantitative analysis of the FOXG1 levels in (A) ( n = 3). (C) Quantitative analysis of the LC3-II levels in (A) ( n = 3). (D) Immunofluorescence staining of the cochlear from the control mice and the D-gal mice with anti-FOXG1 (red), Phalloidin (green) and DAPI (blue). (E) Quantification of FOXG1 expression in (D) ( n = 3). (F) Immunofluorescence staining of the cochlear from the control mice and the D-gal mice with anti-H3K9me2 (green), Phalloidin (red) and DAPI (blue). (G) Immunofluorescence staining of the cochlear from the control mice and the D-gal mice with anti-LC3B (green), Phalloidin (red) and DAPI (blue). (H) Quantification of H3K9me2 expression in (F) ( n = 3). (I) Quantification of LC3B expression in (G) ( n = 3). (J) Western blot of FOXG1 and H3K9me2 expression levels in the HEI-OC1 cells after 72-h treatment with different concentrations of D-gal. (K) Quantitative analysis of the FOXG1 levels in (J) ( n = 3). (L) Quantitative analysis of the H3K9me2 levels in (J) ( n = 3). (M) Western blot of LC3 expression levels in the HEI-OC1 cells after 72-h treatment with different concentrations of D-gal. (N) Quantitative analysis of the LC3-II levels in (M) ( n = 3). NS, not significant, * p < 0.05, ** p < 0.01, *** p < 0.001.
Article Snippet:
Techniques: Western Blot, Expressing, Control, Injection, Immunofluorescence, Staining
Journal: Frontiers in Molecular Neuroscience
Article Title: The H3K9me2-FOXG1-microRNA axis reduces cochlear hair cells damage by modulating autophagy in age-related hearing loss
doi: 10.3389/fnmol.2026.1834102
Figure Lengend Snippet: H3K9me2 may regulate autophagy through FOXG1. (A) Western blot of G9a and H3K9me2 expression levels in the HEI-OC1 cells after 24-h treatment with different concentrations of BIX01294. (B) Quantitative analysis of the G9a levels in (A) ( n = 3). (C) Quantitative analysis of the H3K9me2 levels in (A) ( n = 3). (D) Western blot of FOXG1 and LC3 expression levels in the HEI-OC1 cells after 24-h treatment with different concentrations of BIX01294. (E) Quantitative analysis of the FOXG1 levels in (D) ( n = 3). (F) Quantitative analysis of the LC3-II levels in (D) ( n = 3). (G) Western blot of H3K9me2, FOXG1 and LC3 expression levels in the HEI-OC1 cells following D-gal and BIX01294 treatment. (H) Quantitative analysis of the H3K9me2 levels in G ( n = 4). (I) Quantitative analysis of the FOXG1 levels in (G) ( n = 4). (J) Quantitative analysis of the LC3-II levels in (G) ( n = 4). (K) Western blot of FOXG1 and LC3 expression levels in the HEI-OC1 cells following D-gal treatment and FOXG1 overexpression. (L) Quantitative analysis of the FOXG1 levels in (K) ( n = 3). (M) Quantitative analysis of the LC3-II levels in (K) ( n = 3). (N) Western blot of FOXG1 and LC3 expression levels in the HEI-OC1 cells following BIX01294 treatment and FOXG1 knockdown. (O) Quantitative analysis of the FOXG1 levels in (N) ( n = 3). (P) Quantitative analysis of the LC3-II levels in (N) ( n = 3). NS, not significant, * p < 0.05, ** p < 0.01, *** p < 0.001.
Article Snippet:
Techniques: Western Blot, Expressing, Over Expression, Knockdown
Journal: Frontiers in Molecular Neuroscience
Article Title: The H3K9me2-FOXG1-microRNA axis reduces cochlear hair cells damage by modulating autophagy in age-related hearing loss
doi: 10.3389/fnmol.2026.1834102
Figure Lengend Snippet: FOXG1-induced autophagy activation may be mediated by autophagy-related miRNAs. (A) Expression levels of miR-34a, miR-96, miR-182, and miR-183 in the cochlea of the control mice and the D-gal mice ( n = 3). (B) Expression levels of miR-34a, miR-96, miR-182, and miR-183 in the hippocampus of the control mice and the D-gal mice ( n = 3). (C) Expression levels of miR-34a, miR-96, miR-182, and miR-183 in the cortex of the control mice and the D-gal mice ( n = 3). (D) Expression levels of miR-34a, miR-96, miR-182, and miR-183 in the HEI-OC1 cells after knocking down FOXG1 ( n = 3). (E) Expression levels of miR-34a, miR-96, miR-182, and miR-183 in HEI-OC1 cells treated with D-gal after BIX01294 pretreatment or FOXG1 overexpression ( n = 3). (F) Western blot of LC3 expression levels in the HEI-OC1 cells following inhibition of miR-34a, miR-96, miR-182, and miR-183. (G) Quantitative analysis of the LC3-II levels in (F) ( n = 3). (H) Western blot of FOXG1 and LC3 expression levels in the HEI-OC1 cells treated with BIX01294 combined with miR-34a, miR-96, miR-182, and miR-183 inhibitors, respectively. (I) Quantitative analysis of the FOXG1 levels in (H) ( n = 3). (J) Quantitative analysis of the LC3-II levels in (H) ( n = 3). (K) Western blot of FOXG1 and LC3 expression levels in the HEI-OC1 cells treated with D-gal combined with miR-34a, miR-96, miR-182, and miR-183 mimics, respectively. (L) Quantitative analysis of the FOXG1 levels in (K) ( n = 4). (M) Quantitative analysis of the LC3-II levels in K ( n = 4). NS, not significant, * p < 0.05, ** p < 0.01, *** p < 0.001.
Article Snippet:
Techniques: Activation Assay, Expressing, Control, Over Expression, Western Blot, Inhibition
Journal: Frontiers in Molecular Neuroscience
Article Title: The H3K9me2-FOXG1-microRNA axis reduces cochlear hair cells damage by modulating autophagy in age-related hearing loss
doi: 10.3389/fnmol.2026.1834102
Figure Lengend Snippet: Flow cytometric analysis of apoptosis and ROS levels in the HEI-OC1 cells following inhibition of miRNAs and D-gal treatment. (A) Flow cytometric analysis of apoptosis in the HEI-OC1 cells following inhibition of miR-34a, miR-96, miR-182, and miR-183, and combined with D-gal treatment. (B) Quantification of apoptotic cells in (A) ( n = 3). (C) Quantification of dead cells in (A) ( n = 3). (D) Flow cytometric analysis of ROS levels in the HEI-OC1 cells following inhibition of miR-34a, miR-96, miR-182, and miR-183, and combined with D-gal treatment. (E) Quantification of ROS levels in (D) ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001.
Article Snippet:
Techniques: Inhibition
Journal: Frontiers in Molecular Neuroscience
Article Title: The H3K9me2-FOXG1-microRNA axis reduces cochlear hair cells damage by modulating autophagy in age-related hearing loss
doi: 10.3389/fnmol.2026.1834102
Figure Lengend Snippet: Proteomics analysis of the aging mouse cochlear and the D-gal-induced aging cells. (A) PCA of proteomics data from the cochlear of control and aging mice. (B) Heatmap of DEPs between the control group and the aging group. (C) KEGG enrichment analysis of DEPs between the control group and the aging group. (D) Volcano plot of DEPs between the control group and the D-gal group in HEI-OC1 cells (Up-DEPs shown as red dots; down-DEPs shown as blue dots). (E) KEGG enrichment of upregulated DEPs in the D-gal group. (F) KEGG enrichment of downregulated DEPs in the D-gal group. (G) Volcano plot of DEPs between the control group and the si-FOXG1 group in HEI-OC1 cells (Up-DEPs shown as red dots; down-DEPs shown as blue dots). (H) KEGG enrichment of upregulated DEPs in the si-FOXG1 group. (I) KEGG enrichment of downregulated DEPs in the si-FOXG1 group. (J) KEGG enrichment analysis of the overlapping upregulated DEPs in both the D-gal group and the si-FOXG1 group. (K) KEGG enrichment analysis of the overlapping downregulated DEPs in both the D-gal group and the si-FOXG1 group. (L) Validation results for the top four overlapping upregulated (left four bars) and downregulated (right four bars) DEPs identified in both the D-gal group and the si-FOXG1 group by qRT-PCR ( n = 3). NS, not significant, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Article Snippet:
Techniques: Control, Biomarker Discovery, Quantitative RT-PCR